- Published on:
Havana, Oct 9 (Prensa Latina) The Nimotuzumab drug (Cimaher®), one of Cuba's leading biotechnology products, has reportedly been registered in more than 20 countries, especially for head and neck cancer and glioma in pediatrics.
